Root Financial Partners
STRO icon

Root Financial Partners’s Sutro Biopharma STRO Stock Holding History

Root Financial Partners’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$64 Buy
+4
New +$88 ﹤0.01% 3702

Other funds holding STRO

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Owl Creek Wealth Partners
Owl Creek Wealth Partners Denver, Colorado $355M AUM
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Root Financial Partners's STRO Position: Q3 2026 in Review

Root Financial Partners opened a new position in Sutro Biopharma (STRO) in Q3 2026: 4 shares worth $64. The stake represents ﹤0.01% of the portfolio and ranks #3702 among its holdings.

9 funds tracked by Wall St. Rank hold STRO as of Q3 2026.

  • Root Financial Partners held 4 shares of Sutro Biopharma worth $64 as of Q3 2026.
  • Sutro Biopharma was a new Root Financial Partners position in Q3 2026.
  • Sutro Biopharma made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3702 holding.
  • 9 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.